En
Da
Fr
De
Sv
Deal History
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer/E-commerce
Digital Media / Internet
Industrial Technology
Life Sciences and Healthcare
Software / TMT
Insights
News
Newsletter
Research
About us
Company
Team
Offices
Globalscope
Career
Events
Contact
En
Da
Fr
De
Sv
Main menu button
Team
Deals
Contact
Equity Research
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
H&D Wireless
Hanza
Hanza Holding AB
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Thinc Jetty
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Corporate Finance
Equity Research
In Media
M&A Know-how
Macro and markets
Market Snapshots
22 Mar 2023
Carlsquare weekly market letter: Are we back to 1929 or 2008?
Equity Research
15 Mar 2023
Carlsquare weekly market letter: Tech rebounds as Fed trembles
Equity Research
08 Mar 2023
Carlsquare weekly market letter: Big Evening Star in S&P 500
Equity Research
01 Mar 2023
Carlsquare weekly market letter: Can Junk lead the way?
Equity Research
22 Feb 2023
Carlsquare weekly market letter: Better numbers push stocks lower, thanks to the Fed
Equity Research
15 Feb 2023
Carlsquare weekly market letter: Is SEK at a breakpoint and what does it imply for the stock market?
Equity Research
08 Feb 2023
Carlsquare weekly market letter: MAAGT replaces the FANG companies
Equity Research
01 Feb 2023
Carlsquare weekly market letter: Time to go fishing
Equity Research
25 Jan 2023
Carlsquare weekly market letter: Why doesn't the Fed stop their rate hikes to give the economy some much wanted breathing room?
Equity Research
18 Jan 2023
Carlsquare weekly market letter: The Swedish-German love affair in M&A
Equity Research
11 Jan 2023
Carlsquare weekly market letter: The VC market is bad, but not too bad!
Equity Research
21 Dec 2022
Carlsquare weekly market letter: The Swedish property market is under fire! Time to buy?
Equity Research
14 Dec 2022
Carlsquare weekly market letter: It is a buyers’ market, again!
Equity Research
07 Dec 2022
Carlsquare weekly market letter: Will Santa Claus deliver an IT rally for Christmas?
Equity Research
30 Nov 2022
Carlsquare weekly market letter: The market is at a vulnerable breakpoint ahead of new data
Equity Research
23 Nov 2022
Carlsquare weekly market letter: Will the consumers raise again?
Equity Research
16 Nov 2022
Carlsquare weekly market letter: It’s always darkest before dawn
Equity Research
09 Nov 2022
Carlsquare weekly market letter: Stock market at a breakpoint with energy and gold in focus
Equity Research
02 Nov 2022
Carlsquare weekly market letter: When will Fed change the inflation target => stimulating the stock market?
Equity Research
26 Oct 2022
Carlsquare weekly market letter: Can the upturn in the market, give some energy back to the IPO market?
Equity Research
1
2